Important notification
15.02.2023 To the attention of manufacturers, authorised representatives, economic operators and all stakeholders Please be informed that, starting from 13 […]
Important notification
14.02.2023 To the attention of manufacturers, notified bodies, healthcare institutions and all stakeholders in the field of in vitro diagnostic […]
Press release
10.02.2023 To the attention of interested persons PRAC starts safety review of pseudoephedrine-containing medicines download document …
Press release
27.01.2023 To the attention of interested persons Review of sickle cell disease medicine Adakveo started download document …
Press release
27.01.2023 To the attention of interested persons EMA confirms measures to minimise risk of serious side effects with Janus kinase […]
Press release
13.01.2023 To the attention of interested persons Withdrawal of marketing authorisations for amfepramone medicines within the EU. download document …
Press release
13.01.2023 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 – 12 January […]
Important notification
13.01.2023 For the attention of healthcare professionals and researchers in healthcare institutions who intend to design, manufacture, modify and use […]
Important notification
23.12.2022 To the attention of manufacturers, authorised representatives, economic operators and all stakeholders Please be informed that on 9 December […]
Press release
16.12.2022 To the attention of interested persons EMA recommends withdrawal of pholcodine medicines from EU market download document …